Georgiamune and Menarini Group Enter Exclusive Global License and Collaboration Agreement for GIM-621, a First-in-Class Oral Immuno-Oncology Agent
GIM-621 is a preclinical-stage, first-in-class oral small molecule immunotherapy with potential application across multiple solid tumors. Georgiamune to receive $45 million in upfront and near-term payments, as part of a total deal value of up to...
Akeso Announces Summit Therapeutics and ECOG-ACRIN Cancer Research Group Enter into Phase II/III Clinical Trial Collaboration to Evaluate Ivonescimab in First-Line Biliary Tract Cancer
Becomes the 7th International Registrational Clinical Trial for Ivonescimab Clinical Trial Site Activations in the United States Expected to Begin Q4 2026 HONG KONG, Oct. 21, 2026 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) today announced that...
Agoda and Emerging Travel Group Enter Strategic Partnership
SINGAPORE, Oct. 15, 2026 /PRNewswire/ -- Digital travel platform Agoda and Emerging Travel Group (ETG), a global travel technology company operating the RateHawk, ZenHotels, and Roundtrip brands, have entered into a strategic partnership to expand...
OceanBase and MB Bank Enter into Strategic MOU to Accelerate Database Modernization and Infrastructure Resilience
SINGAPORE, Oct. 2, 2026 /PRNewswire/ -- OceanBase and MB Bank (Military Commercial Joint Stock Bank), a leading Vietnamese banking institution recognized for its digital transformation capabilities and a brand value of more than USD 2 billion,...
Datasea's AI Agent Digital Marketing Services Enter Scaled Commercial Deployment, with Five Agreements Representing Potential Annualized Service Volume of Up to Approximately US$89.4 Million (RMB600 Million)
Five-customer AI agent services advance into actual delivery; CEO reiterates long-term confidence through a previously disclosed US$1.0 million Rule 10b5-1 share purchase plan BEIJING, Sept. 17, 2026 /PRNewswire/ -- Datasea Intelligent Technology...
Transcenta Therapeutics and WuXi Biologics Enter into Strategic Collaboration to Accelerate Commercialization of HiCB Continuous Bioprocessing Technologies
PRINCETON, N.J. and SUZHOU, China, Sept. 9, 2026 /PRNewswire/ -- Transcenta Therapeutics (HKEX: 06628), a global clinical-stage biopharmaceutical company with fully integrated capabilities in discovery, R&D and process development of...
FinChain and KuCoin Enter into Partnership
FUSD Integrated as Collateral Asset into KuCoin RWA Collateral Mirroring Solution (RCMS), Unlocking the Application Value of Yield ‑ Bearing RWA Digital Assets in Offshore Trading and Capital Efficiency Management HONG KONG, Aug. 31, 2026...
Furniture China and Maison Shanghai 2026 Enter Final Countdown
SHANGHAI, Aug. 25, 2026 /PRNewswire/ -- With less than two weeks to go, Furniture China and Maison Shanghai 2026, organized by CNFA and IM Sinoexpo, are entering the final countdown to their September return to Shanghai Pudong, bringing together...
Anbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
TAIPEI, Aug. 24, 2026 /PRNewswire/ -- Anbogen Therapeutics Inc. (TPEx: 7784) ("Anbogen" or the "Company"), a clinical-stage precision oncology company, today announced that it has entered into a Collaborative Research Agreement (CRA) with the...
Henlius and Sandoz Enter Strategic Collaboration to Unlock Global Value of Biosimilars Platform
Collaboration may cover up to 10 proposed monoclonal antibody (mAb) and/or antibody-drug conjugate (ADC) biosimilar assets, with the majority of programs at early development stages Based on the initial arrangements, the total invoiced amount...